{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:13:54Z","timestamp":1786986834993,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceuticals Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016273","name":"Menarini Silicon Biosystems Spa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018787","name":"Novartis Pharma AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006676","name":"Lilly Deutschland GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019944","name":"Sanofi-Aventis Deutschland GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clbc.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:25:05Z","timestamp":1684862705000},"page":"e345-e353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients"],"prefix":"10.1016","volume":"23","author":[{"given":"Marie","family":"Tzschaschel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.P.","family":"Friedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Schochter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Sch\u00fctze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadius","family":"Polasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schindlbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Aivazova-Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"H\u00e4berle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Janni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte Kathrin","family":"Rack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visnja","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clbc.2023.05.011_bib0001","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju066","article-title":"Circulating tumor cells predict survival in early average-to-high risk breast cancer patients","volume":"106","author":"Rack","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.clbc.2023.05.011_bib0002","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-15-1603","article-title":"Pooled analysis of the prognostic relevance of circulating tumor cells in primary breast cancer","volume":"22","author":"Janni","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.011_bib0003","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.molonc.2016.01.001","article-title":"Circulating tumor cells in breast cancer","volume":"10","author":"Bidard","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clbc.2023.05.011_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/130470","article-title":"Time-dependent prognostic impact of circulating tumor cells detection in non-metastatic breast cancer: 70-month analysis of the REMAGUS02 study","author":"Bidard","year":"2013","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.clbc.2023.05.011_bib0005","doi-asserted-by":"crossref","unstructured":"Paoletti C, Hayes DF. Circulating Tumor Cells BT - Novel Biomarkers in the Continuum of Breast Cancer. In: Stearns V, ed. Cham: Springer International Publishing; 2016. p. 235\u201358. Available at: https:\/\/doi.org\/10.1007\/978-3-319-22909-6_10.","DOI":"10.1007\/978-3-319-22909-6_10"},{"issue":"6","key":"10.1016\/j.clbc.2023.05.011_bib0006","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/bcr2940","article-title":"Clinical relevance and biology of circulating tumor cells","volume":"13","author":"Bednarz-Knoll","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2023.05.011_bib0007","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clbc.2023.05.011_bib0008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.critrevonc.2015.10.010","article-title":"Circulating tumor cells in breast cancer-current status and perspectives","volume":"97","author":"Banys-Paluchowski","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.011_bib0009","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2012.194258","article-title":"Circulating tumor cells: liquid biopsy of cancer","volume":"59","author":"Alix-Panabi\u00e8res","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.clbc.2023.05.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2009.44","article-title":"Cancer micrometastases","volume":"6","author":"Pantel","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2023.05.011_bib0011","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/en.2009-0070","article-title":"Obesity and breast cancer: the estrogen connection","volume":"150","author":"Cleary","year":"2009","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.clbc.2023.05.011_bib0012","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/aje\/152.6.514","article-title":"Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk","volume":"152","author":"Van den Brandt","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.011_bib0013","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jnci\/82.4.286","article-title":"Body fat distribution and breast cancer in the framingham study","volume":"82","author":"Ballard-Barbash","year":"1990","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.clbc.2023.05.011_bib0014","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/ije\/28.6.1026","article-title":"Body fat distribution and obesity in pre- and postmenopausal breast cancer","volume":"28","author":"Sonnenschein","year":"1999","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.011_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2015.04.002","article-title":"Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies","volume":"138","author":"Horowitz","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"17","key":"10.1016\/j.clbc.2023.05.011_bib0016","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"issue":"7630","key":"10.1016\/j.clbc.2023.05.011_bib0017","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ Br Med J"},{"issue":"10","key":"10.1016\/j.clbc.2023.05.011_bib0018","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","article-title":"Body mass index and survival in women with breast cancer\u2014systematic literature review and meta-analysis of 82 follow-up studies","volume":"25","author":"Chan","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.011_bib0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2010.29.7614","article-title":"Effect of obesity on prognosis after early-stage breast cancer","volume":"29","author":"Ewertz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.011_bib0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10549-015-3287-5","article-title":"Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials","volume":"150","author":"Fontanella","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2023.05.011_bib0021","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-015-3422-3","article-title":"Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer","volume":"151","author":"Scholz","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.011_bib0022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13058-015-0639-3","article-title":"The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial","volume":"17","author":"Widschwendter","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.clbc.2023.05.011_bib0023","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archinte.165.11.1267","article-title":"Undertreatment of obese women receiving breast cancer chemotherapy","volume":"165","author":"Griggs","year":"2005","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.clbc.2023.05.011_bib0024","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1055-9965.EPI-05-0042","article-title":"Obesity and outcomes in premenopausal and postmenopausal breast cancer","volume":"14","author":"Loi","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"10.1016\/j.clbc.2023.05.011_bib0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/ASO.2006.03.049","article-title":"Effect of obesity on presentation of breast cancer","author":"Porter","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2023.05.011_bib0026","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.bjc.6600209","article-title":"Patient delay and stage of diagnosis among breast cancer patients in Germany: a population based study","volume":"86","author":"Arndt","year":"2002","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.clbc.2023.05.011_bib0027","article-title":"Reduced growth of human breast cancer xenografts in hosts homozygous for the <em>lit<\/em> mutation","volume":"56","author":"Yang","year":"1996","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.clbc.2023.05.011_bib0028","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.clbc.2023.05.011_bib0029","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S1470-2045(08)70235-3","article-title":"Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis","volume":"9","author":"Ma","year":"2008","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.011_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","year":"2008","journal-title":"Lancet Oncol"},{"issue":"5350","key":"10.1016\/j.clbc.2023.05.011_bib0031","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science (80-)"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.011_bib0032","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/cells5020016","article-title":"The NF-\u03baB Pathway and cancer stem cells","volume":"5","author":"Rinkenbaugh","year":"2016","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.clbc.2023.05.011_bib0033","first-page":"378","article-title":"Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention","volume":"67","author":"Picon-Ruiz","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.clbc.2023.05.011_bib0034","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2001.19.5.1539","article-title":"Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Recht","year":"2001","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.011_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-001-0839-x","article-title":"Radiation therapy after mastectomy\u2013interdisciplinary consensus puts and end to a controversy. German Society of Senology","volume":"177","author":"Sauer","year":"2001","journal-title":"Strahlenther Onkol"},{"issue":"3 suppl 9","key":"10.1016\/j.clbc.2023.05.011_bib0036","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.seminoncol.2006.03.016","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"33","author":"Cristofanilli","year":"2006","journal-title":"C Semin Oncol"},{"issue":"33","key":"10.1016\/j.clbc.2023.05.011_bib0037","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1200\/JCO.2007.11.7762","article-title":"Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer","volume":"25","author":"Ignatiadis","year":"2007","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2023.05.011_bib0038","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.2007.13.6523","article-title":"Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse","volume":"26","author":"Pachmann","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.011_bib0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/172460081002500201","article-title":"Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer","volume":"25","author":"Chen","year":"2010","journal-title":"Int J Biol Markers"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.011_bib0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1379-4","article-title":"The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature","volume":"130","author":"Zhao","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2023.05.011_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70069-5","article-title":"Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data","author":"Bidard","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.011_bib0042","first-page":"207","article-title":"Diabetes and cancer: a consensus report","volume":"60","author":"Giovannucci","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.clbc.2023.05.011_bib0043","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00125-011-2169-6","article-title":"Diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations","volume":"54","author":"Wild","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.clbc.2023.05.011_bib0044","doi-asserted-by":"crossref","DOI":"10.1186\/s40608-014-0033-1","article-title":"Altered NK cell function in obese healthy humans","author":"Laue","year":"2015","journal-title":"BMC Obes"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.011_bib0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.21147\/j.issn.1000-9604.2018.03.06","article-title":"Presence of circulating tumor cells is associated with metabolic-related variables in postoperative patients with early-stage breast cancer","volume":"30","author":"Shi","year":"2018","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.011_bib0046","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.amjsurg.2017.06.005","article-title":"Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer","volume":"214","author":"Fayanju","year":"2017","journal-title":"Am J Surg"},{"issue":"suppl 15","key":"10.1016\/j.clbc.2023.05.011_bib0047","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/jco.2011.29.15_suppl.610","article-title":"Circulating tumor cells as a prognostic factor independent of obesity in metastatic breast cancer patients","volume":"29","author":"Giuliano","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:53Z","timestamp":1761513953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1526820923001325"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.011","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}